Long-Term Health-Related Quality of Life, Growth, and Spiritual Well-Being After Hematopoietic Stem-Cell Transplantation
Top Cited Papers
- 20 January 2005
- journal article
- supportive care-and-quality-of-life
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (3) , 599-608
- https://doi.org/10.1200/jco.2005.03.189
Abstract
Purpose: To examine health-related quality of life (HRQOL) and growth, and spiritual well-being in adult survivors of hematopoietic stem-cell transplantation (HSCT) for a malignant disease.Methods: HSCT survivors (n = 662) were recruited through the International Bone Marrow Transplant Registry/Autologous Blood and Marrow Transplant Registry and were drawn from 40 transplantation centers. HSCT survivors completed a telephone interview and a set of questionnaires a mean of 7.0 years post-HSCT (range, 1.8 to 22.6 years). Study measures included a variety of standardized measures of HRQOL and growth and spiritual well-being. An age- and sex-matched healthy comparison (HC) group (n = 158) was recruited using a peer nomination method. The HC group completed a parallel telephone interview and set of questionnaires.Results: Multivariate analysis of variance analyses found the HSCT survivor group reported poorer status relative to the HC group for all HRQOL outcome clusters including physical health, physical functioning, social functioning, psychological adjustment, and dyadic adjustment. In contrast, the HSCT survivor group reported more psychological and interpersonal growth. Mean effect size for the 24 outcome indices examined was 0.36 standard deviations, an effect size often considered clinically meaningful or important. The largest group differences were found for measures of general health, physical function and well-being, depression, cognitive function, and fatigue.Conclusion: The experience of HSCT for a malignant disease has a wide-ranging, longstanding, and profound impact on adult recipients. Relative to healthy controls, HSCT survivors reported poorer physical, psychological, and social functioning but, conversely, more psychological and interpersonal growth, differences that appeared to persist many years after HSCT.Keywords
This publication has 60 references indexed in Scilit:
- The CARES-SF used for prospective assessment of health-related quality of life after stem cell transplantationPsycho‐Oncology, 2003
- Cognitive‐existential group psychotherapy for women with primary breast cancer: A randomised controlled trialPsycho‐Oncology, 2003
- The yellow brick road and the emerald city: Benefit finding, positive reappraisal coping and posttraumatic growth in women with early-stage breast cancer.Health Psychology, 2003
- Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue ScalesJournal of Pain and Symptom Management, 2002
- Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJournal of Pain and Symptom Management, 1997
- Fatigue in women treated with bone marrow transplantation for breast cancer: A comparison with women with no history of cancerSupportive Care in Cancer, 1997
- The Posttraumatic Growth Inventory: Measuring the positive legacy of traumaJournal of Traumatic Stress, 1996
- Quality of life in adult cancer patients treated with bone marrow transplantation—a review of the literatureEuropean Journal Of Cancer, 1995
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- The CES-D ScaleApplied Psychological Measurement, 1977